Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESDignifiHealth Announces CEO and Key Executive Hires

DignifiHealth Announces CEO and Key Executive Hires

DignifiHealth reports Richard Queen has been promoted to Chief Executive Officer of the company, formerly serving as DignifiHealth’s Chief Product Officer and Co-Founder.

Mr. Queen created and developed the clinical intelligence layer that powers DignifiHealth in 2018 and brings more than 15 years of experience in hospital and provider group management, including diverse titles such as Chief Financial Officer, Director of Business Intelligence, and VP of Data Science. Combining his educational background in finance, his vast experience within the healthcare industry, and his more than 20 years in technology and automation, he brings a unique perspective in his vision on the future of healthcare.

James Hale has joined the company as Chief Operating Officer. His notable career includes serving as Head of Platform at Artivest where he worked closely with clients, vendors, and internal teams to drive innovation and accelerate the adoption and growth of Artivest’s web-based platform. Mr. Hale also previously served as Director of Alternative Investments Platform Administration at Raymond James. His extensive experience operationalizing businesses and delivering SaaS platforms to clients will be key in driving DignifiHealth’s performance and scaled growth.

Ali Price has joined DignifiHealth as VP of Marketing & Communications. Ms. Price has more than 15 years of experience managing communications and business advancement efforts. She most recently served as VP of Marketing & Communications for Stifel’s Public Finance division. Throughout her career, Ms. Price has built a reputation as an insightful and thoughtful communications leader and strategist.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy